Plato Data Intelligence.
Vertical Search & Ai.

Tag: Euronext

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

TOKYO, Apr 10, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment...

Top News

Nukkleus to Acquire Mercury Global to Enhance Cross-Border Payments

The fintech firm Nukkleus plans to acquire Mercury Global, a company in the international money transfer sector. The deal entails Nukkleus acquiring Mercury Global through a...

AQEMIA Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline

PARIS–(BUSINESS WIRE)–AQEMIA continues to grow rapidly in its effort to discover new drugs with their generative-AI fueled by deep physics. After raising €30M last...

SMAIO: 2023 Sales up +120% to €5.4 Million

Strong growth in sales driven by the $3m (~€2.8m) milestone payment from NuVasive during H1 2023 Acceleration in sales of the Kheiron system (+40% vs....

Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050

Strasbourg, France & Tokyo, Japan, Jan 9, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based...

Euronext’s €200 Million Share Repurchase Program

Euronext, a pan-European market infrastructure, has announced the initiation of a share repurchase programme, signaling a strategic move driven by strong cash generation capabilities. The programme, with...

SIX Broadens Reach with ETF QOD Europe Launch

SIX Swiss Exchange, a firm in the ETF industry for over two decades, has introduced ETF QOD Europe to provide a comprehensive trading experience. This new...

AFYREN Provides Business Update and Targets for AFYREN NEOXY Operations

AFYREN NEOXY: Improvements underway and new targets for operations: Start of continuous production in 2024 and break-even in 2025 Development continues in France and abroad Finances are...

ProvenRun Secures €15M Series A to Accelerate its Growth

PRESS RELEASEParis, 6th December 2023 - ProvenRun, the cybersecurity software company, announces a successful €15 million fundraising round. This investment is led by Tikehau Capital,...

The 3 best Casino stocks for the sports betting era

Casino stocks are generally having a decent year in 2023. Two of the largest pure-play exchange traded funds (ETFs) are the VanEck Gaming ETF (NASDAQ:BJK) and the Roundhill...

Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™

The Company announces a new identity for its iBiopsy® AI/ML tech-based suite of software as medical devices (SaMD), and business unit. iBiopsy® becomes eyonis™. eyonis™ brand...

Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 – 30, Chicago, IL, USA

AI Theater Presentation: “Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD” Median’s teams will be at booth #4465, South Hall Level 3, to present the latest...

Kalray Announces Availability of New NG-Box NVMe Storage Solution for Data-Intensive and AI Applications

Based on Kalray DPU cards and Dell PowerEdge servers, NG-Box offers fast and scalable on-premises storage for the world’s most demanding data intensive and...

Latest Intelligence

spot_img
spot_img
spot_img

Chat with us

Hi there! How can I help you?